Yahoo
NasdaqGM - Delayed Quote USD

NovaBridge Biosciences (NBP)

1.1950 -0.0150 (-1.24%)
At close: October 30 at 4:00:00 PM EDT
Trade NBP on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
632
-1,551
Cost of Revenue
--
--
--
0
3,947.7918
Gross Profit
--
--
--
3,899.7827
-36,061.6294
Operating Expense
122,634
94,269
51,426
49,608
51,527
Operating Income
-122,634
-94,269
-51,426
-48,976
-53,078
Net Non Operating Interest Income Expense
6,288
7,611
7,486
9,294
4,954
Other Income Expense
-1,208
-1,682
-5,756
-42,535
-92,976
Pretax Income
-117,554
-88,340
-49,696
-82,217
-141,100
Tax Provision
0
0
0
0
103
Net Income Common Stockholders
-75,483
-46,269
-22,230
-207,729
-371,053
Diluted NI Available to Com Stockholders
-75,483
-46,269
-22,230
-207,729
-371,053
Basic EPS
-0.69
-0.48
-0.28
-2.33
-4.24
Diluted EPS
-0.69
-0.48
-0.28
-2.33
-4.24
Basic Average Shares
112,800.0830
95,764.7530
81,186.2490
88,654.0630
82,516.2140
Diluted Average Shares
112,800.0830
95,764.7530
81,186.2490
88,654.0630
82,516.2140
Total Operating Income as Reported
-122,634
-94,269
-51,426
-72,017
-53,078
Total Expenses
122,634
94,269
51,426
49,608
51,527
Net Income from Continuing & Discontinued Operation
-75,483
-46,269
-22,230
-207,729
-371,053
Normalized Income
-74,215
-44,513
-44,341
-50,014
-119,692.2500
Interest Income
6,288
7,611
7,486
9,294
4,954
Interest Expense
--
--
--
101.8537
1.3045
Net Interest Income
6,288
7,611
7,486
9,294
4,954
EBIT
-122,634
-94,269
-51,426
-48,976
-53,078
EBITDA
-121,600
-93,413
-50,448
-47,915
-51,663
Reconciled Cost of Revenue
--
--
--
0
3,947.7918
Reconciled Depreciation
1,034
856
978
1,061
1,415
Net Income from Continuing Operation Net Minority Interest
-75,483
-46,269
-49,696
-82,217
-141,203
Total Unusual Items Excluding Goodwill
-1,268
-1,756
-5,355
-32,203
-28,681
Total Unusual Items
-1,268
-1,756
-5,355
-32,203
-28,681
Normalized EBITDA
-120,332
-91,657
-45,093
-15,712
-22,982
Tax Rate for Calcs
0
0
0
0
0.0003
Tax Effect of Unusual Items
0
0
0
0
-7,170.2500
12/31/2022 - 1/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: